CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma
2018 ◽
Vol 36
(5)
◽
pp. 242.e15-242.e21
2015 ◽
Vol 13
(4)
◽
pp. 280-286
◽
2020 ◽
Vol 26
(1)
◽
pp. 154-162
2016 ◽
Vol 14
(1)
◽
pp. e19-e24
◽
2016 ◽
Vol 96
(2)
◽
pp. E95-E96